人t-PA溶栓突变体的研究进展

被引:4
作者
赵月峨
机构
[1] 北京微生物流行病研究所北京
关键词
t-PA突变体; 溶栓;
D O I
暂无
中图分类号
R346 [];
学科分类号
1001 ;
摘要
人t-PA在机体循环中的纤溶系统中起重要作用,是一种内源性溶血栓因子,t-PA蛋白分子可直接用于溶栓治疗。但天然的t-PA分子在体内半衰期短、极易被清除,因而限制其广泛应用。根据它的结构特点而改造的一系列t-PA变体分子将成为新一代溶栓药物,在溶栓治疗中广泛应用。
引用
收藏
页码:305 / 307
页数:3
相关论文
共 5 条
[1]  
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance[J] . Hariharan Easwaran,Hsing-Chen Tsai,Stephen B. Baylin. &nbspMolecular Cell . 2014 (5)
[2]  
Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells. Yamano Yukio,Shiiba Masashi,Negoro Kenji,Nakatani Ken,Kasamatsu Atsushi,Yamatoji Masanobu,Sakuma Kentaro,Ogoshi Kenji,Iyoda Manabu,Shinozuka Keiji,Yokoe Hidetaka,Wada Takeshi,Fujita Shigeyuki,Iwasawa Shunichiro,Takiguchi Yuichi,Tanzawa Hide. Head and Neck . 2010
[3]  
Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. Peng Bo,Gu Yixue,Xiong Yan,Zheng Guopei,He Zhimin. PloS one . 2012
[4]   Chemotherapeutic inhibitors in the treatment of prostate cancer [J].
Deshmukh, Rahul R. ;
Schmitt, Sara M. ;
Hwang, Clara ;
Dou, Qing Ping .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) :11-22
[5]  
Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases[J] . Mario Pérez-Sayáns,José Manuel Somoza-Martín,Francisco Barros-Angueira,Pilar Gayoso Diz,José Manuel Gándara Rey,Abel García-García. &nbspCancer Letters . 2010 (2)